Mobileye reports Q2 2026 results with $3.8B goodwill impairment, raises guidance on R&D grant

Filed July 23, 2026 · Period ending July 23, 2026 · ~2 min read

Key Changes

• high

  Recorded $3,788 million goodwill impairment charge in H1 2026, reducing goodwill from $8,200 million to $4,911 million. Non-cash charge excluded from adjusted metrics.

  Exhibit 99.1 view on EDGAR →
• high

  Recognized $110 million (GAAP) / $93 million (Non-GAAP) Israeli R&D incentive grant in Q2, offsetting R&D expenses. Grant enacted in Q2 but applies retroactively from Jan 2026; expects $197-$217 million (GAAP) / $180-$200 million (Non-GAAP) for full year. No scheduled expiration.

  Exhibit 99.1 view on EDGAR →
• high

  Raised full-year 2026 revenue guidance to $1,970-$2,020 million (midpoint up $20 million), implying 4-7% growth. Raised adjusted operating income midpoint 88% and reduced GAAP operating loss midpoint 4%, primarily due to R&D grant.

  Exhibit 99.1 view on EDGAR →